Demand for Oral Syrups to Fuel Growth of the Cold Cough and Sore Throat Remedies Market, Finds FMI
Future Market Insights recently published a market study that highlights the growth of the cold, cough, sore throat remedies market during the forecast period, 2016-2026. According to the presented study, the cold cough and sore throat remedies market is set to reach a market value of ~ US$ 45,432.8 million towards the end of 2026 growing at a compounded annual growth rate (CAGR) of around 3.2% through the forecast period.
The market study offers an in-depth analysis of the various factors that are expected to influence the overall dynamics of the market including, the current & historical trends, critical success factors, macroeconomic factors, and more.
Some of the major factors that are likely to influence the growth of the cold cough and sore throat remedies market include, the growing incidences of common cold & cough, steady growth in healthcare spending, high adoption by large-scale pharmacy chains, observable growth in self-medication, and shift from prescription (Rx) to over-the-counter (OTC) status. In addition, the availability of a range of dosage forms coupled with advent of generic drugs into the market are some of the other factors that are expected to boost the growth of the cold cough and sore throat remedies market.
By drug type, antihistamines are likely to dominate the value share of the global cold cough sore throat remedies market. However, decongestants are also expected to garner significant demand from patients worldwide during the forecast period, finds FMI study.
For information on the Research Approach used in the Report, Request Methodology@ https://www.futuremarketinsights.com/ask-question/rep-gb-1292
Emerging Markets Present a Host of Opportunities
The growth of the global market is expected to receive a massive boost owing to high demand from emerging markets such as China, India, Brazil, and Russia among others. According to the analyst at FMI, “The aforementioned regions are tipped to be promising markets especially for over-the-counter (OTC) medication during the assessment period. In addition, as the pharmaceutical industries in the emerging markets is highly dominated by the private sector, pharma companies are vying to establish robust sales and distribution channels in the mentioned countries.” For instance, sensing the growing demand, numerous companies including, Johnson & Johnson Services, Inc., AstraZeneca, and GlaxoSmithKline plc, and more are putting their best foot forward to maximize their market share in the emerging markets.
Consumption of Oral Syrups Expected to Surge
As a large majority of pediatric and geriatric patients opt for delivery of drug dosage in the liquid form, oral syrups segment is expected to gain steady ground during the forecast period. In addition, growing adoption of oral syrups by pharmacy chains in the developed regions such as North America and Europe is likely to play a key role in boosting the sales of oral syrups during the assessment period. Furthermore, the convenience of oral syrups coupled with exponential growth in R&D activities pertaining to oral syrups are some of the other factors that are likely to increase the consumption of oral syrups in the upcoming years.
Cold Cough Sore Throat Remedies Market: Vendor Insights The report includes the company profiles of some of the major market players operating in the market. The leading market players in the market covered in the report include, Reckitt Benckiser Group PLC, Novartis AG, Bayer AG, Johnson & Johnson Services, Inc., Sun Pharmaceutical Industries Ltd., and AstraZeneca plc among others
For more insights into the Market, request a sample of this report@https://www.futuremarketinsights.com/reports/sample/rep-gb-1292